These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 31118602)

  • 41. Characteristics of elderly patients with COPD and newly diagnosed lung cancer, and factors associated with treatment decision.
    Qin J; Li G; Zhou J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1515-20. PubMed ID: 27445471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between plasma hepatocyte growth factor and gefitinib resistance in patients with advanced non-small cell lung cancer.
    Han JY; Kim JY; Lee SH; Yoo NJ; Choi BG
    Lung Cancer; 2011 Nov; 74(2):293-9. PubMed ID: 21440951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity.
    Wang W; Dou S; Dong W; Xie M; Cui L; Zheng C; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3767-3776. PubMed ID: 30538439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases.
    Kawaguchi T; Matsumura A; Fukai S; Tamura A; Saito R; Zell JA; Maruyama Y; Ziogas A; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 Jul; 5(7):1001-10. PubMed ID: 20526205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of clinical characteristics and prognosis of lung cancer patients with CPFE or COPD: a retrospective study.
    Wei Y; Yang L; Wang Q
    BMC Pulm Med; 2024 Jun; 24(1):274. PubMed ID: 38851701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COPD is commonly underdiagnosed in patients with lung cancer: results from the RECOIL study (retrospective study of COPD infradiagnosis in lung cancer).
    Parrón Collar D; Pazos Guerra M; Rodriguez P; Gotera C; Mahíllo-Fernández I; Peces-Barba G; Seijo LM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1033-1038. PubMed ID: 28408813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort.
    Ferketich AK; Niland JC; Mamet R; Zornosa C; D'Amico TA; Ettinger DS; Kalemkerian GP; Pisters KM; Reid ME; Otterson GA
    Cancer; 2013 Feb; 119(4):847-53. PubMed ID: 23023590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations.
    Lim JU; Yeo CD; Rhee CK; Kim YH; Park CK; Kim JS; Kim JW; Lee SH; Kim SJ; Yoon HK; Kim TJ; Lee KY
    PLoS One; 2015; 10(11):e0142306. PubMed ID: 26555338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.
    Biton J; Ouakrim H; Dechartres A; Alifano M; Mansuet-Lupo A; Si H; Halpin R; Creasy T; Bantsimba-Malanda C; Arrondeau J; Goldwasser F; Boudou-Rouquette P; Fournel L; Roche N; Burgel PR; Goc J; Devi-Marulkar P; Germain C; Dieu-Nosjean MC; Cremer I; Herbst R; Damotte D
    Am J Respir Crit Care Med; 2018 Oct; 198(7):928-940. PubMed ID: 29518341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection.
    Sekine Y; Suzuki H; Yamada Y; Koh E; Yoshino I
    Thorac Cardiovasc Surg; 2013 Mar; 61(2):124-30. PubMed ID: 22535670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status.
    Baser S; Shannon VR; Eapen GA; Jimenez CA; Onn A; Lin E; Morice RC
    Chest; 2006 Dec; 130(6):1784-90. PubMed ID: 17166997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review.
    Palma D; Lagerwaard F; Rodrigues G; Haasbeek C; Senan S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1149-56. PubMed ID: 21640513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in chronic obstructive pulmonary disease phenotypes between non-smokers and smokers.
    Ji W; Lim MN; Bak SH; Hong SH; Han SS; Lee SJ; Kim WJ; Hong Y
    Clin Respir J; 2018 Feb; 12(2):666-673. PubMed ID: 27805311
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
    Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S
    Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Video-assisted thoracoscopic lobectomy in non-small-cell lung cancer patients with chronic obstructive pulmonary disease is associated with lower pulmonary complications than open lobectomy: a propensity score-matched analysis.
    Jeon JH; Kang CH; Kim HS; Seong YW; Park IK; Kim YT; Kim JH
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):640-5. PubMed ID: 24052605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease.
    Bugge A; Lund MB; Brunborg C; Solberg S; Kongerud J
    Ann Thorac Surg; 2016 Jun; 101(6):2125-31. PubMed ID: 27016839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Smoking and Chronic Obstructive Pulmonary Disease on All-Cause, Respiratory, and Cardio-Cerebrovascular Mortality.
    Kang HR; Kim SJ; Nam JG; Park YS; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1261-1272. PubMed ID: 38863653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prognosis of non-small cell lung cancer combined with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Wu K; Wang J; Zhao L; Wang P; Duan Q
    Clin Respir J; 2020 Apr; 14(4):389-396. PubMed ID: 31905419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.
    Kumagai S; Marumo S; Arita M; Yamanashi K; Sumitomo R; Otake Y; Shoji T; Fukui M; Katayama T; Okumura N; Huang CL
    BMC Pulm Med; 2017 Dec; 17(1):166. PubMed ID: 29202834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.